Featured Research

from universities, journals, and other organizations

The fear of falling

Date:
May 23, 2010
Source:
Deutsches Aerzteblatt International
Summary:
One in four people over the age of 70 suffers from gait disturbance. To prevent falls, specific treatment should be given. In a new study, researchers in Germany describe methods of differential diagnosis and therapy.

One in four people over the age of 70 suffers from gait disturbance. To prevent falls, specific treatment should be given. In the current issue of Deutsches Ärzteblatt International, Klaus Jahn and colleagues describe methods of differential diagnosis and therapy.

Gait disturbance is defined as unsteadiness during walking that is worse than the normal slowing of old age. It often has multiple causes; in elderly patients, fear is often a precipitating or aggravating factor. A vicious circle often arises in which fear of falling leads to avoidance of movement, and in turn to reduced fitness, lower confidence in one's own balance, increased fear, and increased danger of a fall. Depression and a markedly impaired quality of life can result.

In order for the treatment to be as effective as possible, the type of gait disturbance and its causes must be precisely analyzed. In their article, Jahn et al. present effective diagnostic methods. For example, the observation of parameters such as step length, speed, body posture, and variability while the patient walks a given distance, once with eyes open and once with eyes closed, enables classification of the type of gait disturbance.


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Journal Reference:

  1. Klaus Jahn, Andreas Zwergal, Roman Schniepp. Gait Disturbances in Old Age: Classification, Diagnosis, and Treatment From a Neurological Perspective. Deutsches Ärzteblatt International, 2010; 107 (17): 306-16 DOI: 10.3238/arztebl.2010.0306

Cite This Page:

Deutsches Aerzteblatt International. "The fear of falling." ScienceDaily. ScienceDaily, 23 May 2010. <www.sciencedaily.com/releases/2010/05/100514151922.htm>.
Deutsches Aerzteblatt International. (2010, May 23). The fear of falling. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/05/100514151922.htm
Deutsches Aerzteblatt International. "The fear of falling." ScienceDaily. www.sciencedaily.com/releases/2010/05/100514151922.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins